Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists

AIMS: The objective of this study was to investigate whether baseline receptor activator for nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) serum (s) levels can predict the therapeutic response to TNF antagonists (a‐TNF). METHODS: We studied 75 rheumatoid arthritis patients (81% fema...

Full description

Saved in:
Bibliographic Details
Main Authors: González‐Alvaro, Isidoro, Ortiz, Ana M, Tomero, Eva G, Balsa, Alejandro, Orte, Javier, Laffon, Armando, García‐Vicuña, Rosario
Format: Artigo
Language:Inglês
Published: BMJ Group 2007
Subjects:
Concise Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095335/
https://ncbi.nlm.nih.gov/pubmed/17666448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.071910
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items